Holen Sie sich die Stockscreener-App
4.18
2.48%
0.11
Schlusskurs vom Vortag:
$4.07
Offen:
$4.02
24-Stunden-Volumen:
262.23K
Relative Volume:
1.36
Marktkapitalisierung:
$481.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.75%
1M Leistung:
+0.50%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.02
$4.24
1-Wochen-Bereich:
$3.875
$4.24
52-Wochen-Spanne:
$3.60
$5.14
Novabridge Biosciences Adr Stock (NBP) Company Profile
Firmenname
Novabridge Biosciences Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie NBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBP
Novabridge Biosciences Adr
|
4.175 | 469.13M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.65 | 115.62B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
736.52 | 79.10B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
843.76 | 52.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
389.65 | 51.72B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
201.38 | 42.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Eingeleitet | Leerink Partners | Outperform |
| 2025-09-09 | Eingeleitet | BTIG Research | Buy |
| 2021-12-09 | Eingeleitet | Siebert Williams Shank | Buy |
| 2021-06-02 | Eingeleitet | Daiwa Securities | Buy |
| 2021-03-15 | Eingeleitet | Needham | Buy |
| 2021-03-03 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-25 | Eingeleitet | Piper Sandler | Overweight |
| 2020-12-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-02-12 | Eingeleitet | China Renaissance | Buy |
| 2020-02-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Novabridge Biosciences Adr Aktie (NBP) Neueste Nachrichten
Faraday Future Intelligent Electric Inc (FFAI) looking to reclaim success with recent performance - setenews.com
NovaBridge to present extended dosing data for cancer drug ragistomig - Investing.com
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO - GlobeNewswire Inc.
Are Smart Investors Making the Right Decision? NovaBridge Biosciences. ADR (NBP) - Setenews
NovaBridge subsidiary Visara appoints two key ophthalmology leaders By Investing.com - Investing.com Nigeria
NovaBridge subsidiary Visara appoints two key ophthalmology leaders - Investing.com India
Investors in cash trouble should check out NovaBridge Biosciences. ADR (NBP) - Setenews
Get in on Motorsport Games Inc’s (MSGM) buy-in window today! - Setenews
This trade activity should not be overlooked: Zooz Strategy Ltd (ZOOZ) - setenews.com
There is no way NovaBridge Biosciences. ADR (NBP) can keep these numbers up - setenews.com
Prepare Yourself for Liftoff: Sandisk Corp (SNDK) - Setenews
NBP Financial Statements & ChartsNovabridge Biosciences.Adr MacroTrends - CMLviz
NBP Interactive Stock ChartNovabridge Biosciences.Adr. Stock Analysis - CMLviz
NBP Pivot Points, Technical Analysis and Moving AveragesNovabridge Biosciences.Adr Technicals - CMLviz
Total equity of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
Equity in earnings of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Long term debt to total assets ratio of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
NBP Forecast — Price Target — Prediction for 2026 - TradingView
NBP Stock Price and Chart — NASDAQ:NBP - TradingView
NBPNovaBridge Biosciences. ADR Stock Price and Quote - Finviz
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform - Barchart.com
I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data - Investing.com
I-Mab Rebrands to NovaBridge Biosciences Following Shareholder Approval - TipRanks
I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO By Investing.com - Investing.com South Africa
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO - Investing.com
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday - Benzinga
This Bank of New York Mellon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAcadian Asset Management (NYSE:AAMI), C3.ai (NYSE:AI) - Benzinga
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Benzinga
Kimball Electronics Posts Better-Than-Expected Earnings, Joins Terawulf, Dlocal, Equinox Gold And Other Big Stocks Moving Higher On Thursday - Benzinga
Morningstar’s Best- and Worst-Performing Stocks: 2022 - Morningstar
10 of the Cheapest Stocks of 2022 - Morningstar
The Best- and Worst-Performing Stocks: Q3 2022 - Morningstar
New 5-Star Stocks - Morningstar
ORIC Stock Price | Oric Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
ADPT Stock Price | Adaptive Biotechnologies Corp. Stock Quote (U.S.: Nasdaq) - MarketWatch
Finanzdaten der Novabridge Biosciences Adr-Aktie (NBP)
Es liegen keine Finanzdaten für Novabridge Biosciences Adr (NBP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):